Skip to main content
Share

World's leading clinical conference on bone, joint and muscle health

Programme

Go to Sponsored Sessions

Friday April 12th - GMT Time zone

08:00
Opening of the Congress & commercial exhibition
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR1
Treatment failure: a bad day at the office ? Chairperson : Michael McClung
  • Unmet goals of treated patients Michael McClung
  • Improving efficacy after poor outcomes Bruno Muzzi Camargos
  • Clinical perspectives after a fracture: could it be any worse? Geraldine Altamar Canales
08:00
MR2
Psoriatic disease. A multifaceted disease with musculoskeletal manifestations. Emerging therapies Chairperson : Panagiotis Athanassiou
  • Psoriatic disease: Musculoskeletal manifestations Lambros Athanassiou
  • Psoriatic disease: Comorbidities Ifigenia Kostoglou-Athanassiou
  • Psoriatic disease: Psychosocial implications Yannis Athanassiou
  • Psoriatic disease and rehabilitation Yannis Dionyssiotis
  • Psoriatic disease: Current treatment and emerging therapies Panagiotis Athanassiou
08:00
MR3
Digital health interventions for engaging older adults in exercise – What has been effective and what do consumers want? Chairperson : Mylene Aubertin-Leheudre
  • Implementing physical activity for community-dwelling seniors during periods of isolation Fanny Buckinx
  • Short- and long-term effects of 4 online remote physical activity interventions on physical performances during isolation periods in community-dwelling older adults Mylene Aubertin-Leheudre
  • Understanding older adults’ preferences for engaging in remote interventions for improving physical function: The RAMP international consumer Delphi process David Scott
08:00
MR4
Practical ways to prevent fractures in older adults through focused geriatric assessment Chairpersons : Alfonso J. Cruz-Jentoft & Antonio Cherubini
  • How can the recent World Falls Guidelines be implemented to reduce fracture risk in older people Tahir Masud
  • Screening frailty easily in practice: Validation of Simpler Fried Frailty Scale in different European Countries Fatma Ozge Kayhan
  • Can and how medication review helps us preventing further fractures? Gulistan Bahat
08:00
MR5
Beyond FRAX: important but commonly overlooked risk factors Chairperson : Robert Blank
  • Virtually all fracture sites are associated with adverse post-fracture outcomes Jacqueline R. Center
  • Association between Specific Multimorbidity clusters and the risk of Fracture and Post-Fracture Consequences Thach Tran
  • Self-assessed limited mobility is associated with increased fracture risk in both women and men Dana Bliuc
08:00
MR6
Overcoming the limitations of universal vitamin D cut-offs through a novel metabolic approach Chairperson : Markus Herrmann
  • Functional Assessment of Vitamin D Status by a Novel Metabolic Approach Markus Herrmann
  • 1,25(OH)2D and 1,24,25(OH)3D – expanding our knowledge on vitamin D catabolism beyond VMR Etienne Cavalier
08:00
MR7
The significance of quality indicators in Latin America Chairperson : Juan Carlos Viveros García
  • The Burden of Hip Fractures and the Need for Quality Roberto Enrique Lopez Cervantes
  • Key Quality Indicators for Hip Fracture Care: What to Measure and Why José Francisco Torres Naranjo
  • Implementing Quality Indicators in National Healthcare Systems: Challenges and Success Stories Juan Carlos Viveros García
08:00
MR8
The role of hormones in women’s bone health and wellbeing Chairpersons : Maria Celeste Osorio Wender & Adriana Orcesi Pedro
  • Bone health and hormonal contraception Rogério Bonassi Machado
  • How to manage the early negative impact of premature ovarian insufficiency on bone health? Jose Maria Soares Júnior
  • Bone health and osteoporosis screening in gynecologic cancer survivors Adriana Orcesi Pedro
  • Characterizing body composition and bone health in transgender individuals receiving gender-affirming hormone therapy Edson Santos Ferreira Filho
09:00 - 10:30
Auditorium A
Scientific Session I Chairpersons : Maria Luisa Brandi & René Rizzoli
09:00
Auditorium A
Plenary Lecture 1 Fracture prevention: time to move beyond the primary/secondary dichotomy? Eugene V. McCloskey
Have a sneak peek
09:30
Auditorium A
Oral communications selected from abstracts
09:30
Auditorium A
Oral communication selected from abstracts OC1: COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS BISPHOSPHONATES AMONG TREATMENT-EXPERIENCED POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE U.S. MEDICARE PROGRAM Presenting author: V. C. Brunetti Authors: J. R. Curtis, T. Aurora, Y. Liu, T.-C. Lin, L. Spangler, R. K. Stad, M. Mcdermott and B. D. Bradbury
09:40
Auditorium A
Oral communication selected from abstracts OC2: BMD RESPONSES AT THE LUMBAR SPINE AND TOTAL HIP IN PATIENTS RECEIVING ROMOSOZUMAB, DENOSUMAB AND ALENDRONATE: A POST HOC ANALYSIS OF THE RANDOMISED FRAME AND ARCH PHASE 3 TRIALS Presenting author: B. Langdahl Authors: F. Cosman, L. Gifre, K. Poole, F. Thomasius, P. R. Ebeling, J. P. van den Bergh, E. M. Lewiecki, J. Timoshanko, Z. Wang and C. Libanati
09:50
Auditorium A
Oral communication selected from abstracts OC3: CARDIOVASCULAR SAFETY OF ROMOSOZUMAB IN OSTEOPOROSIS PATIENTS: A TRINETX MULTI-INSTITUTIONAL RESEARCH NETWORK ANALYSIS Presenting author: C.-R. Li Authors: H.-T. Lee and Y.-L. Deng
10:00
Auditorium A
Oral communication selected from abstracts OC4: THE COMPARATIVE EFFECTIVENESS AND CARDIOVASCULAR SAFETY OF ABALOPARATIDE AND TERIPARATIDE IN POSTMENOPAUSAL WOMEN NEW TO ANABOLIC THERAPY: UPDATE OF A REAL-WORLD RETROSPECTIVE Presenting author: J.-Y. Reginster Authors: R. Rizzoli, B. Cortet, Y. Wang, J. Chiodo and B. H. Mitlak
10:10
Auditorium A
Oral communication selected from abstracts OC5: ZOLEDRONIC ACID AND DENOSUMAB ARE COMPARABLE IN DIABETIC OSTEOPOROTIC PATIENTS: A POPULATION-BASED COHORT STUDY Presenting author: V. Rouach Authors: H. Gortler, Y. Greenman, G. Chodick and I. Goldshtein
10:20
Auditorium A
Oral communication selected from abstracts OC6: ANTIRESORPTIVE MEDICATION-RELATED JAW OSTEONECROSIS: AN EUROPEAN EUDRAVIGILANCE DATABASE-BASED RETROSPECTIVE COHORT STUDY Presenting author: S. Ferreira Azevedo Authors: C. Pinto Oliveira, A. R. Prata, I. Cunha and A. Barcelos
10:30 - 12:10
Auditorium A
Scientific Session II Chairpersons : Manju Chandran & Nicholas Harvey
10:30
Auditorium A
Presentation of the ESCEO-IOF Pierre Delmas Medal Jean-Yves Reginster & Nicholas Harvey
10:40
Auditorium A
Plenary Lecture 2 Optimization of lifelong osteoporosis management Michael McClung
11:10
Auditorium A
Oral communications selected from abstracts
11:10
Auditorium A
Oral communication selected from abstracts OC7: CLINICAL IMPACT OF ACUTE SYMPTOMATIC VERTEBRAL FRACTURES IN THE UNITED STATES: AN OBSERVATIONAL STUDY Presenting author: N. Binkley Authors: M. Mcdermott, E. Yeh, J. Lane, J. Cheung, M. Amet and F. Cosman
11:20
Auditorium A
Oral communication selected from abstracts OC8: MULTIMORBIDITY AND RISK OF FALLS, FRACTURES, AND JOINT REPLACEMENTS OVER TWO DECADES: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY Presenting author: L. D. Westbury Authors: C. Pearse, R. Rambukwella, K. A. Ward, C. Cooper and E. M. Dennison
11:30
Auditorium A
Oral communication selected from abstracts OC9: TEN-YEAR FOLLOW-UP OF FRACTURE RISK IN A SYSTEMATIC POPULATION-BASED SCREENING PROGRAMME: THE RISK-STRATIFIED OSTEOPOROSIS STRATEGY EVALUATION (ROSE) RANDOMISED TRIAL Presenting author: K. H. Rubin Authors: T. G. Petersen, B. Abrahamsen, M. Højberg, M. J. Rothmann, T. Holmberg, J. Gram, M. Beck, K. E. Akesson, K. M. Javaid and A. P. Hermann
11:40
Auditorium A
Oral communication selected from abstracts OC10: ELEVATED FRACTURE RISK IN A DANISH COHORT WITH TYPE 2 DIABETES MELLITUS AND MICROVASCULAR DISEASES Presenting author: M. Nasser Authors: T. Grønborg, F. Kristensen, R. Thomsen, A. Vaag, J. Nielsen, K. Højlund, M. Olsen, P. Vestergaard, R. Eastell and M. Frost
11:50
Auditorium A
Oral communication selected from abstracts OC11: ALARMING INCREASE IN BURDEN OF SPINAL FRACTURE IN THE MIDDLE EAST AND NORTH AFRICA: A 30-YEAR SECONDARY ANALYSIS OF THE GLOBAL BURDEN OF DISEASE STUDY 2019 Presenting author: A. Azarboo Authors: A. H. Hoveidaei, A. Ghaseminejad-Raeini, M. S. Khonji, S. H. Hosseini-Asl and K. Pirahesh
12:00
Auditorium A
Oral communication selected from abstracts OC12: DIMINISHING RETURNS OF FALL PREVENTION ON HIP FRACTURE WITH AGE Presenting author: M. Lorentzon Authors: H. Johansson, N. Harvey, E. Liu, M. Schini, L. Vandenput, E. V. McCloskey and J. A. Kanis
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

14:00 - 15:00
Meet-The-Expert Session
14:00
MR1
Complex osteoporosis: case histories Elaine M. Dennison
14:00
MR2
Guidelines for management of hypoparathyroidism Maria Luisa Brandi
14:00
MR3
Machine learning and computer vision - the future of fracture risk assessment? Nicholas R. Fuggle
14:00
MR4
An integrated approach to nutrition in musculoskeletal disease Nicola Veronese
14:00
MR6
‘omics in the future of bone health assessment Etienne Cavalier
14:00
MR7
Guidelines for management of primary hyperparathyroidism Marise Lazaretti-Castro
14:00
MR8
How can we optimize fracture healing? Andreas Kurth
14:00 - 15:00
Podium
Oral presentations of selected posters Chairperson : K. A. Ward
14:00
Podium
P683 EFFICACY AND SAFETY OF CT-P41, A PROPOSED DENOSUMAB BIOSIMILAR, COMPARED TO REFERENCE DENOSUMAB (PROLIA) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS Presenting author: J.-Y. Reginster Authors: E. Czerwinski, A. Strzelecka, K. Szymanowski, S. Postol, A. Poder, J. Supronik, K. Wilk, P. Borowy, T. Budlewski, M. Janowska-Maus, J. Kwiatek, S. H. Kim, J. H. Suh, N. R. Han, N. H. Kim, S. H. Bae and S. L. Silverman
14:06
Podium
P1394 BISPHOSPHONATES SHOW NO ASSOCIATION WITH PREVENTING, SLOWING, OR DELAYING RADIOGRAPHIC CHANGES AND PAIN IN HIP OSTEOARTHRITIS: A FOUR-YEAR STUDY IN FEMALE ADULTS USING DATA FROM THE OSTEOARTHRITIS INITIATIVE STUDY Presenting author: Z. Salis
14:12
Podium
P504 ROMOSOZUMAB AND DENOSUMAB COMBINATION THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS Presenting author: G. Adami Authors: A. Fassio, D. Gatti, O. Viapiana, C. Benini and M. Rossini
14:18
Podium
P512 RELATIONSHIPS BETWEEN SELF-PERCEIVED FRACTURE RISK AND FAMILY HISTORY IN THE HERTFORDSHIRE INTERGENERATIONAL STUDY – THE SAME OR DIFFERENT TO PERCEPTIONS REGARDING HEART DISEASE RISK? Presenting author: G. Bevilacqua Authors: L. D. Westbury, C. Cooper and E. M. Dennison
14:24
Podium
P674 TREATMENT WITH LORECIVIVINT LEADS TO IMPROVED LONG-TERM PATIENT ACCEPTABLE SYMPTOM STATE (PASS) COMPARED TO PLACEBO: DATA FROM PHASE 3 EXTENSION TRIAL Presenting author: C. Swearingen Authors: Y. Yazici, J. Tambiah and P. Conaghan
14:30
Podium
P1167 EFFECT OF ROMOSOZUMAB ON TISSUE THICKNESS–ADJUSTED TRABECULAR BONE SCORE (TBSTT) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND DIABETES: RESULTS FROM THE ARCH STUDY Presenting author: S. Ferrari Authors: D. Betah, R. Feldman, B. Langdahl, M. Oates, J. Timoshanko, Z. Wang and R. Dhaliwal
14:36
Podium
P488 RELATIONSHIPS BETWEEN EARLY LIFE FACTORS AND OSTEOARTHRITIS PAIN: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY Presenting author: F. J. Kirkham-Wilson Authors: L. D. Westbury, N. R. Fuggle, F. Laskou, C. Cooper and E. M. Dennison
14:42
Podium
P935 INCREASED BONE MARROW ADIPOSITY IS RELATED TO HIGHER FRACTURE RISK AND LOWER BONE MINERAL DENSITY IN OLDER SWEDISH WOMEN Presenting author: M. Zoulakis Authors: K. F. Axelsson, H. Litsne, L. Johansson and M. Lorentzon
14:48
Podium
P321 HEALTH-RELATED QUALITY OF LIFE IN SARCOPENIA: CONTENT VALIDITY OF THE SARQOL QUESTIONNAIRE. Presenting author: C. Demonceau Authors: B. Voz, O. Bruyère, J.-Y. Reginster and C. Beaudart
14:54
Podium
P360 WHAT IS THE EFFECT OF HORMONE REPLACEMENT THERAPY (HRT) ON PREVALENCE, INCIDENCE, AND SEVERITY OF OSTEOARTHRITIS (OA) OF THE KNEE, HIP AND HANDS? A SYSTEMATIC REVIEW Presenting author: C. W. Hillman Authors: K. Marino, O. O'Sullivan, S. Kluzek, R. Atkinson and A. Hassan
14:00 - 15:00
Poster Area
Poster Viewing Session I
14:00 - 15:00
Auditorium B
Sponsored Meet-The-Expert Session

* See details on the Sponsored Satellite Symposia page

14:00 - 15:00
MR5
WHO SYMPOSIUM WHO Symposium on Bone Health and Ageing Chairpersons : Anshu Banerjee & René Rizzoli
  • Overview of WHO Technical Work on Bone Health and Ageing Jothees Amuthavalli Thiyagarajan
  • Systematic review of Measurement Properties of instruments to measure the quality of life of older persons with Sarcopenia and Osteoporosis Shaun Sabico
  • Systematic Review of Measurement Properties of Instruments to Assess Risk of Fracture in Older Persons – An update Germain Honvo
  • WHO Global Report on Fractures among Older Persons: An overview Jothees Amuthavalli Thiyagarajan
  • Reflections Jean-Yves Reginster
15:00 - 17:00
Auditorium A
Scientific Session III Chairpersons : Jean-Marc Kaufman & Patricia Clark
15:00
Auditorium A
Plenary Lecture 3 Unravelling the vitamin D megatrial conundrum Bess Dawson-Hughes
Have a sneak peek
15:30
Auditorium A
Oral communications selected from abstracts
15:30
Auditorium A
Oral communication selected from abstracts OC13: PREDICTING THE ONSET OF END-STAGE KNEE OSTEOARTHRITIS OVER TWO- AND FIVE-YEARS USING MACHINE LEARNING Presenting author: Z. Salis Authors: J. Driban and T. McAlindon
15:40
Auditorium A
Oral communication selected from abstracts OC14: MILD COGNITIVE IMPAIRMENT PREDICTS THE ONSET OF SARCOPENIA: A LONGITUDINAL ANALYSIS FROM THE ENGLISH LONGITUDINAL STUDY ON AGEING Presenting author: N. Veronese Authors: F. S. Ragusa, L. Dominguez, L. Smith and F. Bolzetta
15:50
Auditorium A
Oral communication selected from abstracts OC15: COMPARATIVE EFFECTIVENESS OF YOGA AND STRENGTHENING EXERCISE FOR TREATING KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED TRIAL (YOGA TRIAL) Presenting author: B. J. Abafita Authors: D. Aitken, A. Singh, S. Moonaz, C. Ding, S. Drummen, L. Blizzard, A. J. Palmer, G. Jones, K. L. Bennell and B. E. Antony
16:00
Auditorium A
Oral communication selected from abstracts OC16: RADIOGRAPHIC AND PAIN OUTCOMES FROM A PHASE 3 EXTENSION STUDY (OA-07) EVALUATING THE SAFETY AND EFFICACY OF REPEAT LORECIVIVINT INJECTIONS OVER 3 YEARS IN SUBJECTS WITH SEVERE KNEE OSTEOARTHRITIS Presenting author: J. Tambiah Authors: Y. Yazici, C. Swearingen and T. McAlindon
16:10
Auditorium A
Oral communication selected from abstracts OC17: CURRENT SARCOPENIA DEFINITIONS ARE NOT VALID FOR PREDICTING FALLS AND POOR PHYSICAL FUNCTION IN URBAN DWELLING OLDER ADULTS IN SOUTH AFRICA, THE GAMBIA AND ZIMBABWE: RESULTS FROM THE MUFASSA STUDY Presenting author: K. A. Ward Authors: L. K. Micklesfield, L. Gates, T. Manyanga, M. K. Jallow, B. Cassim, Y. Madela, S. Crozier, C. Cooper, A. J. Burton, H. Wilson, R. A. Ferrand and C. L. Gregson
16:20
Auditorium A
Oral communication selected from abstracts OC18: INCREASED RISK OF STROKE IN PATIENTS WITH OSTEOARTHRITIS IN A PROSPECTIVE COHORT OF MEN : THE STRAMBO STUDY Presenting author: M. A. Auroux Authors: R. Chapurlat and P. Szulc
16:30
Auditorium A
Plenary Lecture 4 Bone, biochemistry and beyond: new paradigms in CKD MBD Peter R. Ebeling
Have a sneak peek
15:00 - 16:45
MR5
Committee of National Societies Special Plenary Session Chairperson : Famida Jiwa
15:00
MR5
Tribute to Professor Gemma ADIB, a pioneer in the fight against osteoporosis in the Middle East region Basel Masri
15:10
MR5
OCs1: VARIATIONS IN HOSPITAL LENGTH OF STAY AND PERFORMED SURGICAL PROCEDURES AFTER HIP FRACTURES Presenting author: A. I. Gasparik Authors: L. Lorenzovici, M. Cevei, D. M. Farcas and D. Stoicanescu
15:18
MR5
OCs2: LESSONS FROM RICO: RISK COMMUNICATION IN OSTEOPOROSIS STUDY Presenting author: C. Beaudart Authors: M. Sharma, S. L. Silverman and M. Hiligsmann
15:26
MR5
OCs3: FROM PIXELS TO PREVENTION: AI-POWERED DIGITAL RADIOGRAMMETRY DEMOCRATIZES OSTEOPOROSIS DIAGNOSIS Presenting author: F. Shau-Huai Authors: L. Cheng Wei, L. Chia-Hung, J. Yu-Ming, T. Qingzong and L. Yen-Jun
15:34
MR5
OCs4: VERTEBRAL FRACTURES BY DXA: IS THE CURRENT DEFINITION ADEQUATE? Presenting author: J. L. A. Morales Torres Authors: J. Romero Ibarra and J. Morales Vargas
15:42
MR5
OCs5: ANXIETY AND DEPRESSION ARE ASSOCIATED WITH POOR HEALTH BEHAVIOURS AND INCIDENT FRACTURE AMONG WOMEN: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY Presenting author: L. D. Westbury Authors: G. Bevilacqua, C. Cooper and E. M. Dennison
15:50
MR5
Presentation of the IOF Committee of National Societies Medal Famida Jiwa
16:00
MR5
OCs6: BONE MINERAL DENSITY AND HAND GRIP STRENGTH IN POSTMENOPAUSAL WOMEN WITH FOREARM FRACTURES Presenting author: N. Grygorieva Authors: I. Stets, A. Iniushyna, D. Kurylo and A. Musiienko
16:08
MR5
OCs7: ORTHOGERIATRIC CO-MANAGEMENT FOR OLDER PATIENTS WITH A MAJOR OSTEOPOROTIC FRACTURE: AN OBSERVATIONAL PRE-POST STUDY Presenting author: S. Janssens Authors: A. Sermon, M. Deschodt, K. Fagard, M. Cerulus, H. Cosyns, J. Flamaing, M. Herteleer and M. Dejaeger
16:16
MR5
OCs8: UNITING THE DICHOTOMY BETWEEN PRIMARY AND SECONDARY PREVENTION OF OSTEOPOROSIS – A COMMUNITY- BASED INTERVENTION Presenting author: Y. El Miedany Authors: A. Gadallah, M. Sarhan, M. Elgaafary and A. Ahmed
16:24
MR5
OCs9: HAND GRIP STRENGTH IN PATIENTS WHO DIAGNOSED WITH TYPE 2 DIABETES MELLITUS IN MONGOLIAN FAMILY HEALTH CENTER Presenting author: M. Jaalkhorol Authors: E. Jamsranjav, E. Radnaa, B. Bat-Orgil, G. Ochirdorj and O. Bold
16:32
MR5
OCs10: MACHINE LEARNING TO CHARACTERIZE BONE BIOMARKERS PROFILE IN RHEUMATOID ARTHRITIS Presenting author: G. Adami Authors: D. Gatti, C. Benini, O. Viapiana, A. Fassio and M. Rossini
17:00 - 18:30
Auditorium A
Sponsored Satellite Symposium

* See details on the Sponsored Satellite Symposia page

18:30 - 19:30
Non-Sponsored Symposia
18:30
MR1
Clinical management of patients on anabolic therapy for osteoporosis Chairperson : Bruno Muzzi Camargos
  • Follow-up through imaginological assessment: aDXA, TBS, RX, VFA, 3D-DXA and QCT Bruno Muzzi Camargos
  • Clinical management of patients under anabolic therapy Angela M. Cheung
18:30
MR2
Update in diagnosis and management of fibromyalgia syndrome on the basis of evidence based medicine Chairpersons : Fitnat Dincer & Andreas Winkelmann
  • Update in Diagnosis of Fibromyalgia Syndrome on the Basis of Evidence based Medicine Andreas Winkelmann
  • Update in Pharmacological Management of FMS on the Basis of Evidence Based Medicine Fitnat Dincer
  • Update in Non -Pharmacological Management of FMS on the Basis of Evidence Based Medicine Daiana Popa
18:30
MR3
Skeletal Fragility: new era in the management of the CKD patients Chairpersons : Hanne Jorgensen & Serge Ferrari
  • KDIGO: what’s news in CKD-MBD Thomas Nickolas
  • The Association between Vertebral Fractures and Vascular Calcifications in Patients without and with CKD Maria Fusaro
  • Bone Biopsy: How, When and Why perform it in CKD patients Mathias Haarhaus
18:30
MR4
Vitamin D in rheumatic diseases Chairpersons : Osvaldo Daniel Messina & Jorge L. A. Morales Torres
  • Epidemiology of VD in Rheumatic diseases Patricia Clark
  • Vitamin D and Systemic Lupus Erythematosus, Antiphospholipid syndrome, and Systemic Sclerosis Jorge L. A. Morales Torres
  • Vitamin D levels in patients with rheumatoid arthritis Osvaldo Daniel Messina
18:30
MR7
Artificial intelligence in osteoporosis: including a case study of vertebral fracture detection Chairpersons : Nicholas R. Fuggle & Kassim M. Javaid
  • What is ‘Clinical AI’ and how is it used in Osteoporosis? Nicholas R. Fuggle
  • Ethical Considerations when using of AI in Clinical Practice Ethics Team - The Alan Turing Institute
  • Artificial Intelligence in Osteoporosis: including a case study of vertebral fracture detection: AI for vertebral fracture screening: A UK perspective – Findings of the ADOPT study Kassim M. Javaid